Finance

Lists
Why is 524669 up 2,30%?
Dive Deeper
524669:BOM
Hester Biosciences Ltd
2 240,00 ₹
+2,30%
(+50,40) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524669...
Open
2 206,70 ₹
High
2 240,00 ₹
Low
2 206,70 ₹
Mkt. cap
19,03 млрд
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 ₹
Ex-dividend date
2026 ж. 14 шіл.
P/E ratio
14,12
52-wk high
2 669,00 ₹
52-wk low
1 250,95 ₹
EPS
158,68 ₹
Shares outstanding
8,51 млн
No. of employees
483
Open
2 206,70 ₹
High
2 240,00 ₹
Low
2 206,70 ₹
Mkt. cap
19,03 млрд
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 ₹
Ex-dividend date
2026 ж. 14 шіл.
P/E ratio
14,12
52-wk high
2 669,00 ₹
52-wk low
1 250,95 ₹
EPS
158,68 ₹
Shares outstanding
8,51 млн
No. of employees
483
News stories
From web sources and news partners
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
Sector-
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
709,69 млн
774,15 млн
1,02 млрд
772,44 млн
Cost of goods sold
193,19 млн
207,28 млн
251,52 млн
170,79 млн
Cost of revenue
193,19 млн
207,28 млн
251,52 млн
170,79 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155,01 млн
155,18 млн
264,13 млн
148,84 млн
Operating expense
442,86 млн
433,25 млн
465,39 млн
444,32 млн
Total operating expenses
636,05 млн
640,53 млн
716,91 млн
615,11 млн
Operating income
73,64 млн
133,62 млн
299,41 млн
157,33 млн
Other non operating income
97,27 млн
6,69 млн
-133,21 млн
16,43 млн
EBT including unusual items
170,36 млн
135,24 млн
250,89 млн
1,02 млрд
EBT excluding unusual items
170,36 млн
135,24 млн
203,96 млн
163,33 млн
Income tax expense
27,05 млн
42,14 млн
85,42 млн
49,50 млн
Effective tax rate
15,88%
31,16%
34,05%
4,87%
Other operating expenses
244,31 млн
233,76 млн
58,89 млн
225,04 млн
Net income
144,49 млн
87,65 млн
159,83 млн
969,81 млн
Net profit margin
20,36%
11,32%
15,73%
125,55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
15,79 млн
-
Interest expense
-22,07 млн
-18,22 млн
-15,77 млн
-30,80 млн
Net interest expenses
-22,07 млн
-18,22 млн
20,00 мың
-30,80 млн
Depreciation and amortization charges
43,54 млн
44,31 млн
59,14 млн
70,44 млн
EBITDA
116,32 млн
174,66 млн
330,34 млн
188,26 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары